Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19 Read more
BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD Read more
BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson’s Disease Read more
RxCelerate Establishes Venture Capital Division and Makes First Investment in US Metabolic Disease Company Read more
Gain insight into the latest treatments for Glaucoma and Dry-Eye Disease at Ophthalmic Drugs Conference 2021 Read more